학술논문
1420TiP - ANNOUNCE 2: An open-label phase 1b, and a randomized, double-blind phase 2 study of olaratumab with gemcitabine plus docetaxel in the treatment of patients with advanced soft tissue sarcoma (STS)
Document Type
Abstract
Author
Source
In Annals of Oncology 1 October 2016 27 Supplement 6:vi491-vi491
Subject
Language
ISSN
0923-7534